KRUPA, Pavel, Hana TICHA, Tomáš KAZDA, Radana DYMÁČKOVÁ, Jana ZITTEBARTOVÁ, Anna ODLOZILIKOVA, Libor KOMINEK, Lukas BOBEK, Ales KUDLACEK and Pavel ŠLAMPA. Early toxicity of hypofractionated radiotherapy for prostate cancer. Biomedical Papers of the Faculty of Medicine of Palacký University, Olomouc, Czech Republic. Olomouc: Palacký University, 2016, vol. 160, No 3, p. 435-441. ISSN 1213-8118. Available from: https://dx.doi.org/10.5507/bp.2016.008.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Early toxicity of hypofractionated radiotherapy for prostate cancer
Authors KRUPA, Pavel (203 Czech Republic, guarantor, belonging to the institution), Hana TICHA (203 Czech Republic), Tomáš KAZDA (203 Czech Republic, belonging to the institution), Radana DYMÁČKOVÁ (203 Czech Republic, belonging to the institution), Jana ZITTEBARTOVÁ (203 Czech Republic), Anna ODLOZILIKOVA (203 Czech Republic), Libor KOMINEK (203 Czech Republic), Lukas BOBEK (203 Czech Republic), Ales KUDLACEK (203 Czech Republic) and Pavel ŠLAMPA (203 Czech Republic, belonging to the institution).
Edition Biomedical Papers of the Faculty of Medicine of Palacký University, Olomouc, Czech Republic, Olomouc, Palacký University, 2016, 1213-8118.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 0.894
RIV identification code RIV/00216224:14110/16:00093383
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.5507/bp.2016.008
UT WoS 000392808100016
Keywords in English hypofractionationation; VMAT; volumetric arc therapy; RapidArc; Tumor control probability; Normal tissue complication probability; alternated time schedule
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 4/4/2017 13:39.
Abstract
Hypofractionated accelerated radiotherapy (HART) is now a feasible option for prostate cancer treatment apropos toxicity, biochemical control and shortening of treatment. The aim of this study was to investigate hypofractionated schedules in the treatment of patients with localized prostate cancer.
PrintDisplayed: 26/7/2024 00:29